about
The COL5A1 gene and Achilles tendon pathologyHow much is too much? (Part 2) International Olympic Committee consensus statement on load in sport and risk of illnessCause of exercise associated muscle cramps (EAMC)--altered neuromuscular control, dehydration or electrolyte depletion?Local corticosteroid injection in iliotibial band friction syndrome in runners: a randomised controlled trialSerum electrolyte concentrations and hydration status are not associated with exercise associated muscle cramping (EAMC) in distance runnersTendon and ligament injuries: the genetic component.Muscle cramping in athletes--risk factors, clinical assessment, and management.International Olympic Committee consensus statement: molecular basis of connective tissue and muscle injuries in sport.IOC consensus paper on the use of platelet-rich plasma in sports medicine.Prevention and management of non-communicable disease: the IOC consensus statement, Lausanne 2013.Prevention and management of noncommunicable disease: the IOC Consensus Statement, Lausanne 2013.The IOC Centres of Excellence bring prevention to sports medicine.How much is too much? (Part 1) International Olympic Committee consensus statement on load in sport and risk of injury.Premarathon Evaluations: Is There a Role for Runner Prerace Medical Screening and Education to Reduce the Risk of Medical Complications?Incidence of injury and illness in South African professional male football players: a prospective cohort study.Recent acute prerace systemic illness in runners increases the risk of not finishing the race: SAFER study V.High incidence of injury at the Sochi 2014 Winter Paralympic Games: a prospective cohort study of 6564 athlete days.The incidence and patterns of illness at the Sochi 2014 Winter Paralympic Games: a prospective cohort study of 6564 athlete days.The Epidemiology of Injuries in Football at the London 2012 Paralympic Games.The epidemiology of injuries in powerlifting at the London 2012 Paralympic Games: An analysis of 1411 athlete-days.The epidemiology of injuries at the London 2012 Paralympic Games.A prospective cohort study of 7031 distance runners shows that 1 in 13 report systemic symptoms of an acute illness in the 8-12 day period before a race, increasing their risk of not finishing the race 1.9 times for those runners who started the racThe International Olympic Committee (IOC) Consensus Statement on periodic health evaluation of elite athletes March 2009.Risk of Injuries in Paralympic Track and Field Differs by Impairment and Event Discipline: A Prospective Cohort Study at the London 2012 Paralympic Games.Isoproterenol sensitivity in heat tolerant and relatively heat intolerant men.Aetiology of skeletal muscle 'cramps' during exercise: a novel hypothesis.Illness and injuries in elite football players--a prospective cohort study during the FIFA Confederations Cup 2009.Increased running speed and previous cramps rather than dehydration or serum sodium changes predict exercise-associated muscle cramping: a prospective cohort study in 210 Ironman triathletes.More than 50% of players sustained a time-loss injury (>1 day of lost training or playing time) during the 2012 Super Rugby Union Tournament: a prospective cohort study of 17,340 player-hours.Genetic biomarkers and exercise-related injuries: current clinical applications?The quest to reduce the risk of adverse medical events in exercising individuals: introducing the SAFER (Strategies to reduce Adverse medical events For the ExerciseR) studies.Older females are at higher risk for medical complications during 21 km road race running: a prospective study in 39 511 race starters--SAFER study III.Less experience and running pace are potential risk factors for medical complications during a 56 km road running race: a prospective study in 26 354 race starters--SAFER study II.Transient receptor potential channels and exercise-associated muscle cramping: A tale of multiple complexities.Clinical characteristics of 385 illnesses of athletes with impairment reported on the WEB-IISS system during the London 2012 Paralympic Games.Description and implementation of U-Turn Medical, a comprehensive lifestyle intervention programme for chronic disease in the sport and exercise medicine setting: pre-post observations in 210 consecutive patients.Collagen genes and exercise-associated muscle cramping.The COL5A1 genotype is associated with range of motion measurements.A pathway-based approach investigating the genes encoding interleukin-1β, interleukin-6 and the interleukin-1 receptor antagonist provides new insight into the genetic susceptibility of Achilles tendinopathy.The COL12A1 and COL14A1 genes and Achilles tendon injuries.
P50
Q24301737-06A65EB1-CD2E-43DE-8D90-5DD299D4CB31Q30248424-4E21AAC6-5933-4700-880B-9168EFE027A8Q34871376-C8880A8B-21B7-4C00-818C-12821743D413Q35328807-2100BE70-6B0E-4053-BFE1-91140D8F711DQ35329668-BE875F20-092E-4648-8264-530A9C31017AQ36721538-EADF58E7-6A1F-41F1-B5ED-29B4141814D0Q37060870-464508F5-B7B8-44E2-9BA9-F1A9CCA18F7EQ37060882-142B0FAE-0E87-4DC6-9068-75AA22A753CCQ37812206-4CE99B27-05C4-4CEC-907D-D3B1914D2491Q38151650-64A9F5DC-90BE-4712-8F0C-DDFBE3FE9CDBQ38156293-F61CD736-0485-4112-8290-41B4A40CD6FEQ38239090-463224DD-815E-431B-A244-CFFA17F917CAQ38406076-7699A52B-7799-472F-84F9-AF1482CCD4F1Q38789556-F7027B47-9BE0-4A4F-8C48-4A171FB360E4Q38794627-23C0F118-9EF7-4F1A-BA6F-1145545146DBQ38839575-5C88E265-9174-4857-B12A-FECEE7B00E24Q38852513-2736E570-2373-447E-82CD-BEF843C7D076Q38869352-F8B24EEC-4A07-4471-B0EA-D54403F4B232Q38954716-39979235-C28F-4294-98AE-7274C9C9B2F9Q38954753-CEEF3CDC-4940-4B00-A590-051B63101B9AQ39447740-BD54B862-2914-444F-B820-7E0A6EE0B145Q39655926-F6312D3A-4AEB-4066-BBE2-63B87E0D4FA5Q39949031-A30AB77B-7DD8-4D80-9D9A-7F86A0B53391Q39964944-946ED4D5-7182-4DEC-BC8A-EA690A2D7D62Q41345170-69878F04-DD81-49E3-8A41-B6E41A61DAFBQ41541002-9DE8D410-4334-4918-9812-B35777C67AF6Q43514259-9106C4FA-E8F2-4568-ACF0-E3CB791291A2Q43555447-19017A0E-E6D3-4F01-9373-5F9BA6B76611Q43936209-520CF78D-D8DF-48D0-8491-65E3E8EF3690Q44073479-286BF631-5F35-404D-8C59-24F2235FDB6BQ44189148-30BE884F-618E-44DD-A783-9D7BD68666F0Q44443333-BBDD6814-05AF-4AF5-A90C-DC15A9B52E98Q44487419-D01E760F-F89C-4091-ADC8-8543A12AB0E2Q44579253-6195F5AA-65CB-4780-B170-4B816AFC8254Q44986368-17DE30D7-4838-467A-8C0A-20A8D1AB3BD7Q45344964-F24501C7-ADED-46F1-AA4E-5B884F6B71A2Q45358859-7E4330AE-17B4-4222-9B38-87D1FAC427B5Q45505264-8FA3FB61-421C-4E4D-B49E-74F18F20718CQ46154554-6F1BD086-5A99-4BDF-8A70-670E27C7F0F4Q46157092-272E2653-CDB5-47C1-8773-32F7B5B440D0
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
ricercatore
@it
հետազոտող
@hy
name
Martin Schwellnus
@ast
Martin Schwellnus
@en
Martin Schwellnus
@es
Martin Schwellnus
@nl
Martin Schwellnus
@sl
type
label
Martin Schwellnus
@ast
Martin Schwellnus
@en
Martin Schwellnus
@es
Martin Schwellnus
@nl
Martin Schwellnus
@sl
altLabel
Martin
@en
prefLabel
Martin Schwellnus
@ast
Martin Schwellnus
@en
Martin Schwellnus
@es
Martin Schwellnus
@nl
Martin Schwellnus
@sl
P1006
P214
P244
P1006
P1053
E-6042-2010
P106
P1153
6603663415
P21
P213
0000 0000 5525 3858
P214
P244
no2003090397
P31
P3829
P496
0000-0003-3647-0429
P735
P7859
lccn-no2003090397